Trials / Completed
CompletedNCT03764007
18F-Fluorocholine for the Detection of Parathyroid Adenomas
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 98 (actual)
- Sponsor
- Thomas Hope · Academic / Other
- Sex
- All
- Age
- 13 Years
- Healthy volunteers
- Not accepted
Summary
The investigators are studying the ability of F18 labeled fluorocholine PET to localize parathyroid adenomas in patients with hyperparathyroidism prior to surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 18F-Fluorocholine | Given intravenously |
| PROCEDURE | Positron Emission Tomography (PET) | Imaging technique that uses radioactive agents known as radiotracers to visualize and measure changes in metabolic processes, and in other physiological activities |
Timeline
- Start date
- 2016-09-21
- Primary completion
- 2021-05-31
- Completion
- 2021-05-31
- First posted
- 2018-12-04
- Last updated
- 2021-10-19
- Results posted
- 2021-10-19
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03764007. Inclusion in this directory is not an endorsement.